Clinical Trial Update: Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial is investigating whether pegfilgrastim affects trastuzumab’s anti-tumor activity and ADCC in operable HER2-positive breast cancer. The study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• NEULASTA (pegfilgrastim)

Snippet

Sponsor: Centre Leon Berard | Conditions: HER2-positive Breast Cancer, Operable Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING